See every side of every news story
Published loading...Updated

CaHA Injectable for Facial Use Gains Regulatory Approval in China

Summary by Plastic Surgery Practice
The approval makes it the first calcium hydroxylapatite microsphere injectable product approved in China for facial soft tissue augmentation, according to the company. Shanghai Moyom Biotechnology has obtained a Class III Medical Device Certificate from the China National Medical Products Administration (NMPA 20253130390) for its Aphranel MagiCCrystal CaHA filler. The company says this makes it the first calcium hydroxylapatite microsphere (CaHA…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Plastic Surgery Practice broke the news in on Monday, March 24, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.